Clinical Trial Update: Comparison of Different Dose of Post-transplantation Cyclophosphamide as Graft Versus Host Disease Prophylaxis [Phase 3]

View source ↗

Summary

Phase 3 clinical trial evaluating different doses of post-transplant cyclophosphamide for graft-versus-host disease prophylaxis after transplantation.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Graft-versus-host Disease

Drugs mentioned

• post-transplant cyclophosphamide (cyclophosphamide)

Snippet

Sponsor: Shanghai Jiao Tong University School of Medicine | Conditions: GVHD | Phase 3 | Status: UNKNOWN